World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
60042
World Ranking
10240
National Ranking
5266

Overview

Kenneth Cusi is affiliated with the University of Florida in the United States and specializes primarily in the field of medicine, with a focus on epidemiology, endocrinology, diabetes and metabolism, hepatology, surgery, and molecular biology.

The scientist's research encompasses several topics, including:

  • Liver Disease Diagnosis and Treatment
  • Diet, Metabolism, and Disease
  • Liver Disease and Transplantation
  • Pancreatitis Pathology and Treatment
  • Diet and metabolism studies
  • Hepatitis C virus research
  • Metabolism, Diabetes, and Cancer

Among recent notable publications by Kenneth Cusi are:

  • American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings, 2022, Endocrine Practice

Other frequently referenced papers in the broader research context with co-authors include works published in journals such as Hepatology, Journal of Hepatology, and New England Journal of Medicine, covering topics like new fatty liver disease nomenclature and treatments for nonalcoholic steatohepatitis.

Frequently collaborating co-authors listed include:

  • Zobair M. Younossi
  • Jeffrey V. Lazarus
  • Fernando Bril
  • Vincent Wai-Sun Wong
  • Srilaxmi Kalavalapalli

Kenneth Cusi's publication record spans notable venues such as:

  • Journal of Hepatology
  • Diabetes Care
  • Hepatology
  • Diabetes
  • Journal of the Endocrine Society

The scientist's work is characterized by contributions to clinical guidelines and consensus statements, particularly in the diagnosis and management of fatty liver diseases and related metabolic disorders. This body of research intersects significantly with liver disease, endocrinology, and diabetes.

Best Publications

  • The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

    Naga Chalasani;Zobair Younossi;Joel E. Lavine;Michael Charlton

  • The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

    Naga Chalasani;Zobair Younossi;Joel E. Lavine;Anna Mae Diehl

  • Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

    Mary Elizabeth Patti;Atul J. Butte;Sarah Crunkhorn;Kenneth Cusi

  • The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

    Naga Chalasani;Zobair Younossi;Joel E. Lavine;Anna Mae Diehl

  • A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis

    Renata Belfort;Stephen A. Harrison;Kenneth Brown;Celia Darland

  • Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.

    Kenneth Cusi;Katsumi Maezono;Katsumi Maezono;Abdullah A Osman;Merri Pendergrass;Merri Pendergrass

  • A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

    Philip N. Newsome;Kristine Buchholtz;Kenneth Cusi;Martin Linder

  • Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.

    Kenneth Cusi

  • Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.

    Yoshinori Miyazaki;Archana Mahankali;Masafumi Matsuda;Srikanth Mahankali

  • Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial

    Kenneth Cusi;Beverly Orsak;Fernando Bril;Romina Lomonaco

  • Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies.

    Norbert Stefan;Hans-Ulrich Häring;Kenneth Cusi;Kenneth Cusi

  • A Sustained Increase in Plasma Free Fatty Acids Impairs Insulin Secretion in Nondiabetic Subjects Genetically Predisposed to Develop Type 2 Diabetes

    Sangeeta Kashyap;Renata Belfort;Amalia Gastaldelli;Thongchai Pratipanawatr

  • Relationship Between Hepatic/Visceral Fat and Hepatic Insulin Resistance in Nondiabetic and Type 2 Diabetic Subjects

    Amalia Gastaldelli;Amalia Gastaldelli;Kenneth Cusi;Kenneth Cusi;Maura Pettiti;Jean Hardies

  • Advancing the global public health agenda for NAFLD: a consensus statement.

    Jeffrey V Lazarus;Henry E Mark;Quentin M Anstee;Juan Pablo Arab

  • Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.

    Kenneth Cusi;Agostino Consoli;Ralph A. Defronzo

  • High Prevalence of Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.

    Paola Portillo-Sanchez;Paola Portillo-Sanchez;Fernando Bril;Fernando Bril;Maryann Maximos;Maryann Maximos;Romina Lomonaco

  • Improved Glycemic Control and Enhanced Insulin Sensitivity in Type 2 Diabetic Subjects Treated With Pioglitazone

    Yoshinori Miyazaki;Archana Mahankali;Masafumi Matsuda;Leonard Glass

  • Dose-Response Effect of Elevated Plasma Free Fatty Acid on Insulin Signaling

    Renata Belfort;Lawrence Mandarino;Sangeeta Kashyap;Kelly L Wirfel

  • Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease

    Romina Lomonaco;Romina Lomonaco;Carolina Ortiz-Lopez;Carolina Ortiz-Lopez;Beverly Orsak;Amy Webb;Amy Webb

  • Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease.

    Reenam S. Khan;Reenam S. Khan;Fernando Bril;Fernando Bril;Kenneth Cusi;Kenneth Cusi;Philip N. Newsome;Philip N. Newsome

Frequent Co-Authors

Ralph A. DeFronzo
Ralph A. DeFronzo The University of Texas Health Science Center at San Antonio
Lawrence J. Mandarino
Lawrence J. Mandarino University of Arizona
Amalia Gastaldelli
Amalia Gastaldelli National Research Council (CNR)
Arun J. Sanyal
Arun J. Sanyal Virginia Commonwealth University
Naga Chalasani
Naga Chalasani Indiana University
Joel E. Lavine
Joel E. Lavine Columbia University
Michael Charlton
Michael Charlton University of Chicago
Elizabeth M. Brunt
Elizabeth M. Brunt Washington University in St. Louis
Rohit Loomba
Rohit Loomba University of California, San Diego
Anna Mae Diehl
Anna Mae Diehl Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine offers more than the traditional MD path. A variety of medical billing and coding online courses now provide flexible options for those interested in healthcare administration. These programs can be completed quickly and offer a cost-effective entry into the healthcare sector.

Nursing continues to be a high-demand field, and students can find affordable ways to become a registered nurse. There are cheapest fnp programs and cheapest bsn programs online that make it easier to earn nursing credentials from home while balancing other commitments.

For those already in nursing, further advancement is possible with a phd nursing education online program. This pathway can open doors to academia, research, and leadership roles within healthcare.

Exploring related online degrees expands your options and makes healthcare careers more accessible and flexible than ever before.

Best Scientists Citing Kenneth Cusi

Trending Scientists